Remote Medical Documentation Company Augmedix Closes $19 Million In Funding

By Annie Baker ● November 6, 2019
  • Remote medical documentation company Augmedix announced that it raised $19 million in Series B funding from Redmile, McKesson, DCM, and Wanxiang Healthcare.

Augmedix — a remote medical documentation company — announced recently that it raised $19 million in Series B funding. This round of funding includes investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments, and several others.

With this round of funding, Augmedix plans to use the funding to accelerate product development, including automation capabilities and to strategically scale its technology-enabled service across health systems and private clinics nationwide.

How does Augmedix work? Augmedix turns natural clinician-patient conversation into medical documentation in real-time so that clinicians can focus on what matters most–patient care.

ADVERTISEMENT

The Augmedix platform is powered by a combination of proprietary natural-language-processing technology and medical documentation expert teams. And Augmedix provides clinicians with hardware, smartphones, or Google Glass to securely stream the clinic visit to its cloud-based platform.

Tech-enabled remote specialists are a critical part of Augmedix’s operational platform and utilize proprietary automation modules to generate medical documentation that is accurate, comprehensive, and timely delivered. The service works with over 25 specialties and supports most EHRs. And Augmedix has partnered with over one dozen health systems to combat clinician burnout and increase clinician productivity by more than 30%.

“We appreciate the confidence our investors have shown in Augmedix and are excited by how quickly the industry has adopted our service,” said Manny Krakaris, chief executive officer at Augmedix. “Our service is differentiated because it operates in real-time and is enabled by natural conversation, not burdensome single-party dictation. The combination of our proprietary technology and expert teams reliably delivers the highest quality medical notes thus relieving clinicians of that burden. We will continue to be at the forefront of medical documentation services by investing heavily in technology that will enable us to efficiently deliver additional services and features to our health system customers.”

Fifteen national health systems, including Sutter Health, CommonSpirit Health, and US Oncology — which represent over 10% of clinicians in the US have partnered with Augmedix.

“We have strong confidence in the Augmedix team’s ability to execute on its goal of reducing physician burnout and significantly improving their quality of life,” added Tom Rodgers, senior vice president and managing director at McKesson Ventures. “Augmedix is uniquely positioned to leverage trained medical documentation experts, increasingly enabled by artificial intelligence, to deliver a consumer-grade experience for the clinician that results in more accurate and timely documentation in the most cost-effective manner possible.”

Augmedix has more than one thousand team members worldwide that are focused on developing and delivering the service. 

“Augmedix has expanded our care teams in a novel way, supporting clinicians from primary care, to dermatology and gastroenterology,” explained Albert Chan, MD, chief of digital patient experience at Sutter Health. “Augmedix has helped our efforts to enhance clinician-patient visits and to boost clinician productivity by maximizing our time together.”